Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
101.21
+2.70 (2.74%)
At close: Apr 28, 2026, 4:00 PM EDT
101.21
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:54 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $6.46 billion as of April 28, 2026. Its market cap has increased by 157.29% in one year.
Market Cap
6.46B
Enterprise Value
5.82B
1-Year Change
157.29%
Ranking
Category
Stock Price
$101.21
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $6.46B, an increase of 3,665.64%. That is a compound annual growth rate of 45.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.29B | 15.12% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.75B |
| Belite Bio | 6.37B |
| Apogee Therapeutics | 6.36B |
| Spyre Therapeutics | 6.15B |
| Terns Pharmaceuticals | 6.11B |
| Erasca | 6.11B |
| Centessa Pharmaceuticals | 6.11B |
| Celcuity | 5.92B |